Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis

Daniela Madanes1, Gabriela Meresman2, Sofía A Valla3

  • 1Immunology of the Reproduction Laboratory, Ibyme-Conicet, Buenos Aires C1428ADN, Argentina.

Abstract

Insights

Resveratrol inhibits endometriosis development by reducing cell viability and migration while promoting apoptosis in endometrial cells. It also modulates gene expression related to angiogenesis and stemness, suggesting a multifaceted therapeutic potential.

Area of Science:

  • Gynecology
  • Cell Biology
  • Pharmacology

Background:

  • Endometriosis is a chronic, estrogen-dependent inflammatory disease.
  • Current treatments for endometriosis have limitations and side effects.
  • Resveratrol, a natural polyphenol, has demonstrated anti-inflammatory and anti-cancer properties.

Purpose of the Study:

  • To investigate the inhibitory effects of resveratrol on endometriosis development in vitro.
  • To explore the mechanisms by which resveratrol affects endometriotic and endometrial cells.

Main Methods:

  • In vitro cultures of primary endometriotic stromal cells, immortalized endometrial stromal (St-T1b), and endometriotic epithelial (12Z) cells were used.
  • Cell viability, apoptosis, and migration were assessed using MTT assay, FITC Annexin V assay, and wound healing assay, respectively.
  • Gene expression related to cell migration, angiogenesis, and stemness was evaluated by quantitative real-time PCR (qRT-PCR).

Main Results:

  • Resveratrol significantly decreased cell viability and migration while increasing apoptosis in both cell lines.
  • Resveratrol treatment reduced the expression of genes involved in angiogenesis, including MMP-2/TIMP-1, VEGF, and Ang-1.
  • Resveratrol modulated stem cell phenotype markers, increasing Notch-1, KLF-4, SOX-2, and TERT, while affecting Snail-1, OCT-4, Vimentin, Msi-1, and NANOG expression differentially.

Conclusions:

  • Resveratrol exhibits potent inhibitory effects on cell behavior crucial for endometriosis development.
  • The compound differentially affects growth, apoptosis, migration, and stem cell phenotype of endometrial and endometriotic cells in vitro.
  • Resveratrol holds potential as a therapeutic agent for endometriosis.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.7K